World Enteric Disease Testing Market to Grow Steadily, States VPG in In-demand Research Report Now Available at MarketPublishers.com
07 Sep 2016 • by Natalie Aster
LONDON – The worldwide enteric disease testing market is forecast to see steady growth at a CAGR of close to 9% in the offing. In the recent years, such enteric diseases as diarrhea, typhoid fever, and cholera, have been on the rise amid the global population. Healthcare facilities worldwide are increasingly using the isothermal nucleic acid amplification method for the rapid diagnosis and detection of pathogens. The ability of this specific and sensitive technology to effectively detect pathogens without the use of thermocyclers will lead to this sector’s extensive growth over the projected period.
Geography-wise, Americas are anticipated to see sustained growth in the years to come. Increased demand for molecular diagnostic tests and the enhanced level of awareness about enteric diseases among people are projected to fuel the market growth across this region going forward.
The bacterial enteric diseases presently dominate this market. The high prevalence of gastrointestinal diseases, like typhoid fever and diarrhea, will stimulate the demand for bacterial enteric disease testing amongst patients in the offing.
The immunoassay testing segment grabbed around 50% of the market as of 2015, and it is poised to see enhanced adoption moving forward due to the high portability and fast turnaround time of this diagnostic technology.
The worldwide enteric disease testing market is very fragmented with various small- and medium-sized vendors offering a slew of enteric disease testing products. The emerging economies of India, China, and Brazil open up novel opportunities for players to introduce their respective test instruments and kits.
Cepheid, bioMerieux, DiaSorin, Beckman Coulter/Danaher, Ortho-Clinical Diagnostics, Becton Dickinson, Abbott, ID Biomedical/GSK, Roche, and SeraCare, among others, are the promising industry players.
In-demand report “World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities” created by VPG provides an in-depth analysis of the enteric disease testing market globally, focusing on the USA, Europe (Spain, Germany, France, Italy, and the UK) and Japan.
The study presents test volume and sales projections by market segment and country, and also presents sales figures and estimates of market shares for leading suppliers of enteric disease diagnostic products, based on test and country. Additionally, the research report assesses market applications of the various emerging technologies like monoclonal antibodies (mAbs), IT, molecular diagnostics, immunoassays, etc. It gives an overview of features and performance characteristics of key analyzers utilised for enteric disease testing. The report offers profiles of the dominant suppliers as well as potential market entrants engaged in the development of novel products and technologies. Furthermore, the report canvasses emerging opportunities, alternative strategies for market penetration, barriers to market entry and also the risks incurred when entering a market, and strategic planning issues.
Actual scientific views on etiology and epidemiology are offered for Campylobacter, Cryptosporidium, Enterovirus, E. Coli, Rhinovirus, Salmonella, Vibrio, Rotavirus, Shigella, and Yersinia.
More studies by the publisher can be found at VPG page.